285 related articles for article (PubMed ID: 4744607)
41. [Editorial: Pathoclinical problems in Hodgkin's disease].
Mirek T
Patol Pol; 1975; 26(3):309-23. PubMed ID: 1208143
[No Abstract] [Full Text] [Related]
42. [Hodgkin's disease in pediatrics].
Penchansky L; Muriel FS
Arch Argent Pediatr; 1970 Jul; 68(5):146-59. PubMed ID: 4920384
[No Abstract] [Full Text] [Related]
43. [Clinical evaluation of combined treatment of stage III(B) Hodgkin's disease].
Kanaev SV; Golovanov SG; Girshovich MM; Gershanovich ML
Vopr Onkol; 2006; 52(5):525-30. PubMed ID: 17168360
[TBL] [Abstract][Full Text] [Related]
44. [Causes for failures in the treatment of localized forms of lymphogranulomatosis].
Pakulina LE; Chekharina EA
Vopr Onkol; 1973 May; 19(5):36-41. PubMed ID: 4714734
[No Abstract] [Full Text] [Related]
45. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
Muwakkit S; Geara F; Nabbout B; Farah RA; Shabb NS; Hajjar T; Khogali M
Radiat Oncol Investig; 1999; 7(6):365-73. PubMed ID: 10644060
[TBL] [Abstract][Full Text] [Related]
46. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Chronowski GM; Wilder RB; Tucker SL; Ha CS; Sarris AH; Hagemeister FB; Barista I; Hess MA; Cabanillas F; Cox JD
Cancer; 2002 Dec; 95(12):2534-8. PubMed ID: 12467067
[TBL] [Abstract][Full Text] [Related]
47. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy.
Smith RS; Chen Q; Hudson MM; Link MP; Kun L; Weinstein H; Billett A; Marcus KJ; Tarbell NJ; Donaldson SS
J Clin Oncol; 2003 May; 21(10):2026-33. PubMed ID: 12743158
[TBL] [Abstract][Full Text] [Related]
48. Patterns of treatment failure in pediatric and young adult patients with Hodgkin's disease: local disease control with combined-modality therapy.
Krasin MJ; Rai SN; Kun LE; Merchant TE; Metzger ML; Kaste SC; Howard SC; Hudson MM
J Clin Oncol; 2005 Nov; 23(33):8406-13. PubMed ID: 16293871
[TBL] [Abstract][Full Text] [Related]
49. [Correlation of morphological types of Hodgkin's disease with its clinical course].
Starzyk H; Gabryś K; Lawińska B
Pol Tyg Lek; 1976 May; 31(20):845-7. PubMed ID: 951238
[No Abstract] [Full Text] [Related]
50. Hodgkin's disease with rapidly advancing pulmonary infiltrates.
Am J Med; 1968 Feb; 44(2):270-9. PubMed ID: 5635678
[No Abstract] [Full Text] [Related]
51. Hodgkin's disease 1972-1977.
Feiner AS; Mahmood T
Rocky Mt Med J; 1979; 76(1):17-20. PubMed ID: 419343
[No Abstract] [Full Text] [Related]
52. Stage I Hodgkin's disease. Comparison of surgical staging with incidence of new manifestations in lymphogram- and prelymphogram-studied patients.
Ibrahim E; Fuller LM; Gamble JF; Jing BS; Butler JJ; Gehan EA
Radiology; 1972 Jul; 104(1):145-51. PubMed ID: 5033578
[No Abstract] [Full Text] [Related]
53. Long-term results of the E.O.R.T.C. randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin's disease.
Tubiana M; Henry-Amar M; Hayat M; Breur K; van der Werf-Messing B; Burgers M
Eur J Cancer (1965); 1979 May; 15(5):645-57. PubMed ID: 116855
[No Abstract] [Full Text] [Related]
54. Experience with a new technique for "total node" irradiation--Hodgkin's disease.
Nisce LZ; Geller W; D'Angio GJ
Br J Radiol; 1974 Feb; 47(554):108-11. PubMed ID: 4817450
[No Abstract] [Full Text] [Related]
55. [Over 4-year observations of children after recurrence of Hodgkin's disease].
Armata J; Moryl-Bujakowska A; Cyklis R
Pol Tyg Lek; 1987 Aug; 42(33):1016-9. PubMed ID: 3697353
[No Abstract] [Full Text] [Related]
56. [Prognostic value of the clinical indicators in Hodgkin's disease].
Baĭsogolov GD; Khmelevskaia ZI; Shishkin IP
Vestn Akad Med Nauk SSSR; 1978; (1):54-9. PubMed ID: 626026
[No Abstract] [Full Text] [Related]
57. Primary management of Hodgkin's disease.
Aisenberg AC
N Engl J Med; 1968 Jan; 278(2):93-5. PubMed ID: 4863778
[No Abstract] [Full Text] [Related]
58. International symposium on Hodgkin's disease. Session 2. Histopathology and experimental cytology. Invited discussion: Synthesis and implications for the etiology, pathogenesis and spread of Hodgkin's disease.
Berard CW
Natl Cancer Inst Monogr; 1973 May; 36():261-3. PubMed ID: 4355349
[No Abstract] [Full Text] [Related]
59. [Hodgkin's disease in children--personal observations].
Urasiński T; Chełkowska H; Kurzawa-Nowakowska J; Chlebcewicz-Szuba W; Podraza W; Skwira J
Pol Tyg Lek; 1988 Dec; 43(50):1623-6. PubMed ID: 3256804
[No Abstract] [Full Text] [Related]
60. Hodgkin's disease in Connecticut: histology and age distribution.
O'Conor GT; Correa P; Christine B; Axtell L; Myers M
Natl Cancer Inst Monogr; 1973 May; 36():3-8. PubMed ID: 4744598
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
